FEB 27, 2019 9:00 AM PST

Keynote Presentation: Fully Automated IHC Multiplexing: Techniques and Assay Development

Presented at: Drug Discovery 2019
Sponsored by: Roche Diagnostics
Speaker
  • DISCOVERY Reagent & Training Lead, Companion Diagnostics (CDx) & DISCOVERY, Roche Tissue Diagnostics
    Biography

      Mr. Hellewell has been with Roche Tissue Diagnostics (RTD) for 8 years where he has held several positions within the company. He began his career with RTD UK where he held sales and applications positions. In 2016 he relocated to Tucson, AZ to take up a global role with customer support for RTD. In 2017 he joined the DISCOVERY International Business team as Global Reagent and Training Lead, where he manages their reagent portfolio and global DISCOVERY training activities for customers and RTD personnel.


    Abstract

    Multiplexing IHC is a technique that is increasing in demand as more and more researchers and physicians are being tasked with doing more with less. With multiplexing, you have the advantage to view different targets and their levels of expression in relation to one another. In this presentation, we will review the different technologies and techniques that are currently available to assist with developing a multiplex assay. After a brief overview of the technologies, we will apply some of those technologies and walk through an example of optimizing a multiplex assay. Although digital analysis of multiplexed slides can be an important factor in the interpretation of a multiplexed assay, this presentation will focus on and emphasize the staining aspects of the assay optimization.

    Learning Objectives: 

    1. Understand the utility and methods for multiplexing
    2. Understand the principles behind multiplex assay development


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    DEC 07, 2020 9:00 AM PST
    DEC 07, 2020 9:00 AM PST
    Date: December 7, 2020 Time: 9:00am (PST), 12:00pm (EST) The simultaneous detection of biomarkers on tissue samples plays a fundamental role in the study of the tumor microenvironment. Multi...
    FEB 27, 2019 9:00 AM PST

    Keynote Presentation: Fully Automated IHC Multiplexing: Techniques and Assay Development

    Presented at: Drug Discovery 2019
    Sponsored by: Roche Diagnostics

    Specialty

    Biomarkers

    Immunology

    Molecular Diagnostics

    Health

    Cancer Diagnostics

    Next-Generation Sequencing

    Genetics

    Pathology

    Research

    Cancer Research

    Virology

    Pcr/rt-Pcr/real-Time Pcr

    Cell

    Oncology

    T-Cells

    Geography

    North America33%

    Asia33%

    Europe22%

    Registration Source

    Website Visitors89%

    Job Title

    Facility/Department Manager33%

    Medical Laboratory Technician33%

    Scientist33%

    Organization

    Biotech Company33%

    Manufacturer & Biotech/pharma11%

    Distribution/sales11%

    Manufacturer - Other11%

    Consultant11%

    Hospital11%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more